University Of Toronto, Canadian Biotech Company Collaborate On Cannabinoid-Based COVID-19 Treatment

A Canadian biopharmaceutical company focused on cannabinoid-based products has been awarded a Mitacs grant (sponsored by the Canadian government) to work on a treatment for lung inflammation associated with COVID-19, in tandem with the University of Toronto’s faculty of pharmacy.

Before going further into detail, it’s important to note the project seeks to find a way to reduce inflammation caused by the coronavirus and resulting COVID-19, rather than trying to find a cure.

Click Here for the rest of the article.

Now is the time to be a leader in the CBD industry. Get Certified!

Joe Medrano, ARM, CCBDCComment